echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Professor Zhu Jianwei's team from Shanghai Jiaotong University discovered broad-spectrum neutralizing antibodies against SARS-CoV-2

    Professor Zhu Jianwei's team from Shanghai Jiaotong University discovered broad-spectrum neutralizing antibodies against SARS-CoV-2

    • Last Update: 2022-03-04
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Since the first positive COVID-19 case was confirmed in late 2019, the SARS-CoV-2 virus has caused more than 400 million infections worldwide


    After the outbreak of the new crown epidemic, the team of Professor Zhu Jianwei of the Engineering Research Center for Cell Engineering and Antibody Drugs of the Ministry of Education cooperated with many domestic and foreign enterprises and institutions to clone and screen the B cells of recovered patients to obtain a number of SARS-CoV-2 viruses.


    The study first collected blood samples from patients who had recovered from the new crown, isolated memory B cells from them, and then cloned hundreds of IgG antibody molecules


    Figure 1.


    Then the research team explored the effect of some major mutation sites and major mutant strains on the activity of antibody 2G1, and found that mutation sites such as N439K, Y453F, E484K and N501Y, as well as Alpha, Beta, Gamma and Delta strains that caused concern were all affected by The activity of 2G1 did not constitute a significant effect (Fig.


    Figure 2.


    This study evaluated the in vivo activity of antibody 2G1 using both a transgenic mouse model and a rhesus monkey model


    The structural analysis results of cryo-electron microscopy showed that the antibody 2G1 bound to the tip region of the S protein trimer through extensive hydrophobic interactions, and the binding area to the S protein was very small, avoiding most of the mutation sites.


    Figure 3.


    In this study, a series of valuable SARS-CoV-2 neutralizing antibodies were screened through B cell cloning technology, which has very positive significance for the treatment of new crown infection and the control of new crown epidemic


    Paper link : https:// class="Article-source form-horizontal">


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.